subject: U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 [print this page] In 2009, the U.SIn 2009, the U.S. market forcardiac rhythm management (CRM), electrophysiology and ablation devices was valued at $7.63 billion. This market includes:
Implantable Cardioverter-Defibrillators (ICDs)
Pacemakers
Cardiac Resynchronization Therapy devices (CRTs)
Cardiac stimulation leads
External defibrillators
Ablation catheters
Diagnostic electrophysiology (EP) catheters
Intracardiac ultrasound (ICE) catheters
Electrophysiology (EP) stimulators
Cardiac monitoring devices
Over the forecast period, the CRM, electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced CRM devices. Within the cardiac rhythm management, electrophysiology and ablation markets, companies such as Boston Scientific, Biosense Webster, Medtronic, Philips, St. Jude Medical and Zoll lead the market, among many others.
This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available.
